INBX — Inhibrx Biosciences
Median target
$245
calls from the last 12 months
Implied return
+133.9%
median target vs. price
Coverage
3 analysts · 3 calls
updated in the last 12 months
Consensus
3/0/0+3 net
Buy / Hold / Sell
Which analysts are behind INBX's consensus?
See every current rating, price target and the analysts' track records for Inhibrx Biosciences — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 3 analysts with calls on INBX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
INBX elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-16 | Insiders | Kayyem Jon FaizDirector | Insider purchase | 5.0K sh @ $100.00 | $500K |
| 2026-09-15 | Insiders | Manhard KimberlyDirector | Insider sale | 500 sh @ $105.05 | $53K |
| 2026-09-14 | Insiders | Manhard KimberlyDirector | Insider sale | 500 sh @ $110.26 | $55K |
| 2026-09-11 | Insiders | Manhard KimberlyDirector | Insider sale | 500 sh @ $111.78 | $56K |
| 2026-09-09 | Insiders | Manhard KimberlyDirector | Insider sale | 500 sh @ $115.80 | $58K |
| 2026-09-08 | Insiders | Lappe MarkChief Executive Officer | Insider purchase | 9.7K sh @ $112.28 | $1.1M |
| 2026-09-08 | Insiders | Lappe MarkChief Executive Officer | Insider purchase | 6.6K sh @ $100.64 | $665K |
| 2026-09-08 | Insiders | Lappe MarkChief Executive Officer | Insider purchase | 5.9K sh @ $99.29 | $585K |
| 2026-09-08 | Insiders | Kayyem Jon FaizDirector | Insider purchase | 5.0K sh @ $113.52 | $568K |
| 2026-09-08 | Insiders | Forsyth DouglasDirector | Insider purchase | 2.5K sh @ $114.65 | $287K |
More: insider activity · executive branch · trending